Determination of the level of exposure during and after a chemical incident is crucial for the assessment of public health risks and for appropriate medical treatment, as well as for subsequent health studies that may be part of disaster management. Immediately after such an incident, there is usually no opportunity to collect reliable quantitative information on personal exposures and environmental concentrations may fall below detectable levels shortly after the incident has passed. However, many substances persist longer in biological tissues and thus biological monitoring strategies may have the potential to support exposure assessment, as part of health studies, even after the acute phase of a chemical incident is over. Reported successful applications involve very persistent chemical substances such as protein adducts and include those rare cases in which biological tissues were collected within a few hours after an incident. The persistence of a biomarker in biological tissues, the mechanism of toxicity, and the sensitivity of the analysis of a biomarker were identified as the key parameters to support a decision on the feasibility and usefulness of biological monitoring to be applied after an incident involving the release of hazardous chemicals. These input parameters could be retrieved from published methods on applications of biomarkers. Methods for rapid decision making on the usefulness and feasibility of using biological monitoring are needed. In this contribution, a stepwise procedure for taking such a decision is proposed. The persistence of a biomarker in biological tissues, the mechanism of toxicity, and the sensitivity of the analysis of a biomarker were identified as the key parameters to support such a decision. The procedure proposed for decision making is illustrated by case studies based on two documented chemical incidents in the Netherlands.
Introduction
An acute chemical incident, or disaster, may be defined as ''a situation in which people are potentially exposed to hazards to which they are vulnerable, with resulting public concern, and the possibility of immediate or delayed risks to health'' (Wisner and Adams, 2002) . Such events include fires, explosions, leakages, and accidental or deliberate releases of toxic substances that may cause illness, injury, disability, or death. Determination of the level of exposure during, and after, such incidents is crucial for the assessment of public health risks and appropriate medical treatment, as well as for subsequent health studies (WHO, 1997 (WHO, , 2009 ). Health studies that include exposure assessment might contribute to effective disaster management (Bongers et al., 2008; Van den Berg et al., 2008) .
Immediately after a chemical incident, exposure assessment is often limited to a restricted number of environmental measurements, usually conducted by the fire department. These measurements can be supplemented later by measurements conducted by experts such as hazmat teams. The (often short) duration of the primary exposure, the limited time available to deal with exposure issues (relative to other priorities such as the saving of lives), and the poor information on the identity of the toxic chemicals in an early phase of an incident are particular problems that can result in discrepancies between the desired and attainable exposure data (WHO, 1997) . The quality of information collected in this early phase after an incident may be barely sufficient to distinguish between areas of high and low exposure. Hence, uncertainties remain with regard to the actual levels to which individual subjects have been exposed. Many substances persist longer in biological tissues for which reason biological monitoring provides a good alternative for characterizing personal internal exposure to chemical substances, integrating uptake by different routes of exposure.
Within the present context, biological monitoring is defined as the standardized and repeated systematic collection, pretreatment, storage, and analysis of body tissues to assess the internal dose of a xenobiotic substance by analysis of the parent substance and/or a product of biotransformation. An appealing element in the use of products of biotransformation as biomarkers is that the bioavailability and metabolic bio-activation of chemicals is taken into account, including inter-individual variability in genetic constitution and acquired traits.
In those cases, in particular, in which it is not possible to collect environmental samples during an incident, for example, because of administrative or technical problems, the analysis of biological tissues may be the only remaining alternative to support exposure assessment. The use of biomarkers to estimate exposure should therefore always be considered in health studies after disasters (WHO, 1997 (WHO, , 2009 ). Examples of specific aims of applying biological monitoring as a tool in exposure assessment are presented in Table 1 .
Decisions on the implementation of biological monitoring can be placed within the broader framework of health studies after disasters. The main objectives of disaster health outcome assessment include providing information (a) at the individual level, (b) at the group level of the affected population, as well as (c) at the societal level. From the perspective of the individual victim, the goal of the information collected could be to optimize the medical treatment of that individual. At the group level, the outcome of biological monitoring may contribute to public health. On a societal level, health studies may also serve as a signal of recognition of the problems of survivors. For them, it may be important to know that their possible exposure to toxic substances is being taken seriously. If enhanced exposure can be ruled out, it might have a reassuring effect and may prevent speculations about possible exposure to toxic substances. Moreover, it could be seen as an intervention in itself (Van den Berg et al., 2008) .
A decision to apply biological monitoring needs to be taken as soon as possible after an incident by the emergency response authorities. A method to support such rapid decision making is needed (Bongers et al., 2008) . The aim of this study is to define a stepwise procedure to predict the usefulness and feasibility of applying biological monitoring after a chemical incident. We will identify the parameters needed for making a timely decision and provide this information available for 15 relevant chemical substances. The use of the procedure will be elaborated in two case studies extrapolated from documented incidents in the Netherlands.
Methods

Basic Considerations
Within the present context, a basic point of departure is that biological monitoring may be useful in determining whether any significant exposure has occurred, especially if the predicted exposure is expected to be sufficiently high to induce adverse health effects. As will be elaborated below, this can be assessed by use of intervention values for emergency response (IVERs). The most relevant IVERs are set for different exposure durations (generally from 10 min to 8 h). Therefore, after a chemical incident a biomarker is useful if it can be used as approximation of the (time-weighted average) ambient exposure during the chemical incident and be related to possible (adverse) health effects through the use of these IVERs. Hitherto, the following input for evaluation and decision making for the usefulness and feasibility of biological monitoring in a given exposure situation can be defined:
1. Toxico-kinetic parameters, such as the biological half-life of the biomarker and the pattern of excretion, are necessary for a quantitative retrospective exposure assessment. 2. Toxicity mechanism-based criteria: retrospective assessment of the environmental exposure will only be relevant if the exposure is expected to have been high enough to induce significant adverse health effects. 3. Analytical criteria: an adequate analytical method with sufficient accuracy and precision is needed for a quantitative determination of the biomarker level.
These criteria will be further discussed below.
Toxico-Kinetic Parameters
The possibility of detecting a chemical substance at a certain specific time point after cessation of the exposure is determined by the persistence of the biomarker in biological tissues. Depending on the type of biomarker, the pattern of elimination may vary; for example, from blood many parent substances and their metabolites will follow a first-order pattern of elimination (a logarithmic pattern of initial rapid decay, followed by a tail-shaped slow decrease). A similar For those substance with a background in the general population.
Biomonitoring following chemical incidents Scheepers et al. pattern is expected in urine but this is attenuated by retention of urine in the bladder. For biomarkers that remain intracellular, such as hemoglobin adducts, the elimination will be much slower and follow a linear decay with a half-life dependent on the lifespan of the cell population (zero-order kinetics).
Toxicity Mechanism-Based Criteria
Several programs have been initiated to facilitate rapid decision making by emergency response units in case of chemical incidents. In these programs IVERs are used as action values. Within the present context, the terminology of the acute exposure guideline levels (AEGLs) program (NRC, 2001; Krewski et al., 2004) will be used as these are internationally most widely used. To establish these IVERs the toxicity profile of a chemical is evaluated and three air concentrations (i.e., AEGL-1, AEGL-2, and AEGL-3, representing action levels) are derived that mark the transitions between four categories of increasing health effect (see Supplementary Information, Table 1 ).
Below the AEGL-1, no relevant health effects are to be expected and the public would not or barely notice the presence of a chemical contaminant in the air (detectability). Between AEGL-1 and AEGL-2, some slight effects may occur, such as slight eye irritation, but no further severe irreversible health effects are anticipated (discomfort). Between AEGL-2 and AEGL-3, exposure might result in severe and/or irreversible health effects, or in effects that could impair escape reactions (e.g., narcosis and severe eye irritation) or (disability). Exposures above AEGL-3 are life threatening.
AEGL-2 is the most important action level and because of its definition (i.e., transition level for health-threatening exposure) it can be used as a key parameter for the determination of the usefulness of biological monitoring. This is straight forward when the AEGL-2 is based on a systemic health effect because biomarker levels also relate to systemic availability of a toxic substance and/or intermediate. The AEGL-2 can also be based on local effects such as upper tract irritation but even then it might still be possible that systemic effects for which biological monitoring is useful occur at higher exposure concentrations between the AEGL-2 and the AEGL-3.
Analytical Criteria
If a validated analytical method is available and the optimal sampling strategy is determined, it is useful to verify whether the expected biomarker values are at detectable levels at the time of sample collection. For this, the predicted biomarker concentration can be compared with the limit of detection (LOD) or, for quantification purposes, the predicted value can be compared with the limit of quantification (LOQ). If no information on the LOQ is provided, three times the value of the LOD was used for practical reasons.
Selection of Chemical Substances that may be Involved in Chemical Incidents
The relevance of chemical substances for the Netherlands was assessed based on the Register Risk Situations Hazardous Substances (Dutch: Register Risicosituaties Gevaarlijke Stoffen, RRGS) that contains the frequency of occurrence of chemical substances as reported by the municipalities (this is a legal requirement by 2008). This registry is made public in the format of risk maps (www.risicokaart.nl). Some substances were added because they may be important constituents of process emissions and fires, such as acrolein, hydrogen cyanide, hexavalent chromium in chromates, and polycyclic aromatic hydrocarbons (PAH) in airborne and particulate emissions. Four of the substances (acrylonitrile, ethylene oxide, hydrogen fluoride, and hydrogen sulfide) were also selected as acute exposure threshold level (AETL) case study substances (Trainor et al. 2006 ).
Obtaining Key Parameters for 15 Selected Chemicals
Relevant chemical properties and absorption, distribution, metabolism, and elimination (ADME) parameters were mostly obtained from bibliographical databases (Pubmed, Medline, Excerpta Medica). Some Internet sources (RTECS, TOXNET, GESTIS, IARC Monographs, ATSDR, and the Health Council of the Netherlands, the ACGIH BEI documentation and DFG MAK Kommission documentation) were consulted. The pattern of elimination is ruled by the half-life of the biomarker that reflects the persistence of the biomarker in body tissue. If for a biomarker more than one half-life was reported, we selected the longest reported so-called terminal half-life. For some biomarkers no human data could be retrieved from literature. If no human data were available, animal data were used as an approximation. The elimination half-life should therefore be used as an indicative value, rather than a value representative for the population. Most data were based on adults. Only for dioxin, data were also available for children.
The sensitivity of the chemical analysis of the biomarker can be valued from the reported LOD or LOQ. In this overview, the lowest value for these parameters was reported. This was normally also the value that was reported most recently. These data were supplemented with a declaration of LOD/LOQ values by laboratories that provide routine analysis of biomarkers.
Incident Scenarios
Incident scenarios that were used are based on documented incidents in the Netherlands. The benzene emission (case 1) was related to a spill that occurred in the Rotterdam port on Tuesday, 18 March 2003 at 0815 hours. In reality, the atmosphere was slightly unstable with temperatures of 4 1C at 10 m and 2.2 1C at 200 m (stability class B2), with a ground temperature of 7 1C. For the purpose of this study a fictitious worst case was assumed with a much higher outdoor air and ground temperature of 25 1C. This caused the emission of benzene vapor to increase from 130 kg/min to 309 kg/min, causing a threefold higher release (from 7789 kg to 18,498 kg) after 1 h.
The acrylonitrile incident (case 2) occurred in Amersfoort on Tuesday, 20 August 2002, when at 1103 hours a spill was discovered. The tank wagon had been leaking since approximately 0500 hours. In reality, only a small unknown quantity leaked from the tank load. In the extrapolated fictitious scenario we just assumed that 50,000 of the total load of 56,000 kg of the load had been spilled, causing an emission of 9.5 kg/min. This was calculated using Areal Locations of Hazardous Atmospheres (ALOHA) software version 5.4.1.2 (EPA, 2009b).
Results
Stepwise Procedure for Decision Making
On the basis of the abovementioned considerations a stepwise procedure is proposed to assess the usefulness and feasibility of biological monitoring after a chemical incident (Figure 1 ).
The first step is based on the premise that in case of an accidental chemical release, biological monitoring will be useful if it can be anticipated that there is a reasonable certainty that the AEGL-2 has been exceeded, because only in such a case significant adverse health effects may be expected. However, there may be occasions in which it is not possible to predict whether the AEGL-2 has been exceeded or occasions in which there is significant public concern about the exposure. In these cases, biological monitoring may still be considered if steps 3-6 are fulfilled (see below).
The second step addresses the situation that the AEGL-2 can also be based on local effects such as eye or upper respiratory tract irritation. Internal exposure levels are usually not related to these kinds of local effects and estimation of the internal exposure by biological monitoring is not useful in such cases. However, in these cases one should verify whether systemic effects can be expected once the AEGL-2 is exceeded (step 2a). As a rule of thumb, if the exposure is estimated to be at least two to three times the AEGL-2 (step 2b), it can be anticipated that these systemic effects may occur and one should continue with step 3.
In step 3 the most suitable biomarker should be selected, based on specificity to the substance of exposure. For 15 priority substances we have searched the literature for different options for biomarkers (Table 2 ). For most biomarkers the half-lives are known (step 4). If the half-life of the biomarker is not determined empirically, it may be derived using quantitative structure activity relationships (QSARs). The chemical substances that were selected to study the feasibility of using biological monitoring in the case of a chemical incident are listed in Table 2 . This selection contains 12 singular substances and 3 substances that are part of a group or mixture. Furthermore, the selection contains 10 organic substances and 5 are inorganic substances. Of the inorganic substances, three are metals. The substances represent a great variety of health end points. Important local end points are local irritancy and pulmonary edema and systemic health end points include neurological effects, vascular shock, hemolysis, effects on the gastrointestinal tract and cardio-dysrythmia, effects on metabolism, reproduction toxicity, mutagenicity, and carcinogenicity. The list includes seven substances that are classified as known human carcinogens (IARC category 1). For two chemicals (dioxin and PAH) no information was available in the registry because they are not usual industrial or commercial products.
An adequate analytical method with sufficient accuracy and precision is needed for a quantitative estimate (step 5). In step 6 it is determined how long after the end of exposure the biomarker can still be detected. The estimation of the critical period of time between the end of the exposure period and the time of sample collection t s is based on a calculated biomarker level higher than the LOQ of the analytical method (see Appendix A) or higher than the background biomarker level in the general population (if this is substantially higher than the LOQ).
It is useful to determine which value of t s is the minimum time that should be available for the preparation of proper sample collection. In the Netherlands, the minimum value of t s is estimated to be 72 h for a population-based study. The time needed to collect biological materials from a subgroup such as first responders may be much shorter, especially if previous arrangements have been made, such as availability of the sample collection materials. It is noted here that in the Netherlands there are no ethical requirements to apply biological monitoring as long as the result of biological monitoring is in line with providing the best health care for the victims. As outlined in the introduction, reliable information on the identity and magnitude of exposure can, and will, provide information that is in the interest of an adequate treatment and public health care.
In Table 3 , the input parameters discussed above are presented for the selection of 15 priority chemicals in the Netherlands.
Using the Stepwise Procedure
The stepwise approach will be illustrated by two cases that are realistic extrapolations from documented chemical incidents in the Netherlands. These cases were selected to include two biomarkers that follow either zero-order, or firstorder, kinetics in their pattern of elimination. This provides an opportunity to show differences in the equations and calculations needed to predict the time window for collection of biological tissues. environmental office using a portable photo ionization detector (PID, MiniRae, Rae Systems, San Jose, CA, USA). During the first and second day, concentrations of around 300 p.p.m. were measured at 200 m downwind from the incident location. For this case, it is assumed that on the first day eight workers and four policemen were exposed for B8 h without wearing effective respiratory protection.
The indicative measurement of 300 p.p.m. indicates that the interim AEGL-2 of benzene for an 8-h exposure period of 200 p.p.m. is exceeded (step 1: yes). The AEGL-2 is based on depression of the central nervous system, which is a relevant end point (step 2; EPA, 2009a). For this case, S-phenylmercapturic acid (SPMA) in urine is the biomarker of preference because of its sensitivity and specificity to benzene exposure (step 3, see Supplementary Information, Table 2 ). The predicted level of SPMA at the end of an 8-h exposure period is extrapolated using a regression equation describing the relationship between inhalation exposure and excreted levels of SPMA in workers (see Appendix A). Using this equation, an SPMA excretion of E9000 mg/l was calculated to correspond to the AEGL-2 of 200 p.p.m.; a documented fast elimination corresponded to a half-life of 9.0 ± 4.5 h (step 4). The LOQ for SPMA in urine is 1 mg/l but the 95 percentile in the general population is higher: 7.3 mg/l (Scheepers, 2009) (step 5). On the basis of these data it is calculated that spot urine samples should be collected within 3-4 days after the end of exposure (step 6, see Appendix A). Collection of multiple spot samples is recommended if a quantitative exposure estimate is required (step 7). For interpretation, there are sufficient human data on SPMA to take into account possible confounders such as background exposures due to active smoking and air pollution. Besides supporting exposure assessment, the outcome of biological monitoring may support treatment of health effects in individuals such as on CNS and blood cells and support decisions related to the possible treatment of these health effects.
Fictitious Case 2: Acrylonitrile Release from a Tank Wagon in Amersfoort
Early in the morning, health authorities were notified of several health complaints of railway personnel and inhabitants of the residential area in Amersfoort. The complaints were of a ''strong, irritant, onion smell'' and 21 persons were admitted to hospital, of whom 12 patients were admitted to the intensive care unit in a critical condition. It took some Not confirmed, Lewalter et al. (1985) GF-AAS (1990) time before the probable cause of the smell was found. According to railway authorities these serious health complaints were possibly attributable to a spill of acrylonitrile from a railway wagon on the central railway station in Amersfoort. The sirens were immediately set off to alert the public. Messages were broadcasted on the emergency channels on radio and TV to advise the public in the residential area to stay indoors and keep windows and doors closed. The warning reached the public apparently too late to prevent further serious injuries, because approximately 1 h after the start of the incident, the number of persons admitted to hospital with serious complaints of eye irritation and upper airway complaints reached 60. At 0945 hours, the fire department covered the spill area with foam to reduce evaporation. It is estimated that during the morning approximately 50,000 kg of the product leaked from a railway wagon on the switchyard of the railway station.
The product formed a circular puddle stretching approximately 9 m in each direction around the leaking tank wagon. The vapor cloud was carried to the residential area by a weak southwestern wind (1 m/s). The toxic vapor cloud reached the first residents at 175-200 m. Owing to the late warning, a 1-h exposure to acrylonitrile is considered realistic because inhabitants were not evacuated and were not able to close windows and shut off mechanical ventilation at an early stage of the incident. Furthermore, it is estimated that the proposed AEGL-2 value for a 1-h exposure of 57 p.p.m. was exceeded in a significant part of the residential area (step 1). This is based on the assumption that the total mass of 50 tonnes of the product would cause a puddle of 250 m 2 and the ground temperature would be 12 1C. Using ALOHA it was calculated that the total release would amount to 547 kg, resulting in an AEGL-2 contour extending 132 m from the source. For this case, it is proposed to consider biological monitoring of acrylonitrile exposure for inhabitants of the residential area who were present within the AEGL-2 contour. The AEGL-2 is based on a local effect (step 2A) but the AEGL-3 is 100 p.p.m., which is within a factor 2 of the AEGL-2 (EPA, 2007).
Step 2B also applies for the residents but within a smaller contour (step 2B). The preferred biomarker is the acrylonitrile hemoglobin (N-2-cyanoethylvaline) adduct in blood because of its persistence, sensitivity, and specificity for exposure to acrylonitrile (step 3, see Supplementary Information, Table 3 ). Chemically stable adducts normally follow zero-order kinetics with a half-life of 0.5 times the lifespan of erythrocytes (126 days in humans) (step 4). Human data were used to extrapolate from the AEGL-2 to a predicted adduct level at the end of the exposure incident of E8142 mg/l blood at the end of the incident (see Appendix A). The LOQ of this biomarker is 0.05 mg/l blood (step 5). Using zero-order kinetics it can be calculated that blood samples could be collected over a period of up to 150 days (step 6, see Appendix A). It is further recommended to conduct repeated blood sampling (e.g., once every month for 3-5 months) to be able to reconstruct exposures retrospectively in individuals with a relatively high level of adducts in the first blood sample (step 7). This allows correction for increased adduct levels in smokers and possible inter-individual differences in toxicokinetic parameters. Biomarker results may also support decisions for medical treatment of those victims.
Discussion
The experiences with applying biological monitoring methods in previously reported chemical incidents will be discussed to determine the potential usefulness of biological monitoring. The strengths and weaknesses of using a formal procedure for decision making will also be discussed. The use of the input parameters is a main issue for discussion. Issues related to the implementation of biological monitoring strategies (sampling collection strategy and interpretation of results) will be indicated briefly and some guidelines formulated as a preparatory tool for dealing with chemical incidents. Last but not least, the implication of biological monitoring for risk management and risk communication will be discussed.
Success Factors
Biological monitoring of mercury, methylmercury, PCBs, and dioxin after chemical incidents proved successful because of the persistence of these substances in body tissues (Bertazzi, 1991; Ackermann-Liebrich et al., 1992; Aubin et al., 1994; Bertazzi et al., 1998; Needham et al., 1999; Clewell et al., 2008 ; see Supplementary Information, Table 4 for a literature overview).
The use of protein adducts as biomarkers also provided a relative long lifespan with well-known kinetics such as in the case of sulfur mustard , acrylamide (Hagmar et al., 2001) , ethylene oxide (Tates et al., 1995) , dichlorvos (Mason, 2000) , and acrylonitrile (Bader and Wrbitzky, 2006) .
After two incidents in Japan involving Sarin, samples were collected within a few hours. Some of these samples were not analyzed until several months later because the necessary analytical techniques were yet to be developed (Minami et al., 1997; Polhuijs et al., 1997; Noort et al., 1998; Fidder et al., 2002) . The results of these delayed chemical analyses confirmed the suspicion that the clinical symptoms in the victims were actually caused by Sarin exposure.
Successful quantitative reconstruction of exposure levels after an incident have been reported, based on the measurement of protein adducts (Tates et al., 1995; Bader and Wrbitzky, 2006) and on the measurements of reaction products to enzymes in plasma and erythrocytes (Mason, 2000) . In Table 4 , an overview of the success factors based on past performance is given.
Complicating Factors
In the literature, factors were reported that delayed or prevented the use of a systemic and standardized approach to analysis of body tissues (see Supplementary Information, Table 4 ). The most important obstacles were related to recruitment of study subjects and technical problems such as contamination and loss of samples during transport and storage (Ackermann-Liebrich et al., 1992) , and formal restrictions such as the lack of permission for analysis of body tissues (Ackermann-Liebrich et al., 1992) , delay in sample collection because of too long discussions about the necessity of biolocial monitoring (Traupe et al., 1997) , and lack of funds (Dayal et al., 1992) . Many studies reported limitations with respect to the involvement of study subjects (Slottje et al., 2005a, b) or a too small population size (PerezCadahia et al., 2007) .
Stepwise Procedure for Decision Making
A decision tree is considered useful not only in preparing for biological monitoring campaigns after an incidental chemical release, but also in the decision-making process. Biological monitoring can be used to estimate the actual exposure of a human population. However, this method places significant demands on human and financial resources. It is therefore desirable to apply it only if there is sufficient certainty that people have been exposed to concentrations that are high enough to cause adverse health effects and that the biomarker will still be detectable at the time of sample collection. The proposed decision tree has been developed to meet these needs, and is illustrated by the acrylonitrile and benzene examples. This tool will help to avoid sampling and analyses of biological samples in cases in which biological monitoring has no added value.
If AEGL values have not been established, this might be a reason to refrain from the use of biological monitoring; however, this method should be considered in high-exposure situations with substances producing systemic effects and judged by comparison with alternative threshold values such as OELs (see Supplementary Information, Table 5 ).
Sampling Collection Strategy
For a quantitative analysis, it is of particular interest to collect precise data as to the onset and the duration of the exposure. Furthermore, it is recommended to perform repeated measurements in time. For those biomarkers that follow zero-order, or first-order kinetics, three or more measurements support a calculation of the biomarker level retrospectively, to the time point estimated as the end of the chemical exposure after incident. More than three time points of adduct determination will further improve the reliability of the initial quantitative exposure estimate that is calculated by extrapolation from a regression line.
Interpretation of Biomarker Levels
The biomarker level in a biological tissue (C e ) can be related to the external concentration, based on relationships between ambient inhalation exposure levels and biomarker levels that have already been derived for biological limit values (ACGIH, 2009; DFG, 2008, see Supplementary Information, Table 5 ). If such relationships have not yet been established, it is possible to use physiologically based pharmacokinetic (PBPK) models to derive a calculated estimate, especially for those substances for which such a PBPK model was used to derive an AEGL (Bruckner et al., 2004; Krewski et al., 2004; Boyes et al., 2005; Bos et al., 2006) . Clewell et al. (2008) have recently proposed a procedure for a simple direct translation from biomarker levels to ambient exposure estimates using exposure conversion factors (ECFs). These factors take into account the biological variability within a population by using an ECF distribution (Clewell et al., 2008) . Using these calculations, it is possible to predict whether biomarker levels correspond to an exposure that exceeds an established IVER. As the derivation of ECF distributions could be time consuming, it would be necessary to establish these values for different chemicals in advance.
Preparedness
If biological monitoring is considered a possible means of exposure assessment before an incident, suitable arrangements should be made in advance. Below, some aspects of preparedness are discussed.
1. Preparing a database with the key parameters relevant for the decision tree. These data include updated information on the half-lives of biomarkers in humans and on the LOQ of analytical methods available for the determination of biomarkers in body tissues. In addition, IVERs are usually easily available but for (groups of) substances for which no IVERs are available, data sources should be identified beforehand. 2. Materials, such as needles and containers for sample collection, may be kept in stock at a central repository.
Containers used for collection of urine could be pretreated (e.g., acid rinsed) and kept in stock, ready for use. 3. Protocols for sample collection, transport, and storage may be prepared for large groups of chemical substances for which the same physicochemical and technical conditions apply. 4. Questionnaires needed to support interpretation of outcomes of biological monitoring campaigns could be compiled for large groups of chemicals. 5. Computer models such as PBPK models could be made available for immediate use for reverse modeling of the relationship of a biomarker value with the external exposure (to evaluate if the exposure exceeded an intervention level at the time of the incident). ECF distributions could be prepared in advance.
Risk Management
If biological materials can be analyzed in an early stage after the incident, the outcome of these measurements may be used in decisions concerning the medical treatment of individuals.
In individuals who suffer from health effects, such data may confirm the identity of a specific substance that can then be considered as a possible cause and the severity of the signs of intoxication may be related to the biomarker level, for example, in the case of neurological symptoms (Hagmar et al., 2001) or inhibition of different types of cholinesterase activity in plasma or erythrocytes after exposure to an organophosphor ester insecticide, carbamate pesticide, or to a nerve agent Polhuijs et al., 1997; Tsuchihashi et al., 1998; Mason, 2000; Fidder et al., 2002) . If the results of biological monitoring become available in a later stage, that is, after victims have died or survivors have completely recovered, these results are not relevant to the medical treatment of individuals (Tates et al., 1995; Alarie, 2002; Clewell et al., 2008) . However, in these cases, these obtained data may still have a role in improvement of first response to chemical incidents and medical support of victims suffering from intoxications in the future.
Risk Communication
It is important to relay the message to the victims that results of a biological monitoring campaign will be reported anonymously on a group basis (Scheepers, 2009) . Individual results will usually only be communicated with the physician treating the victim, for example, in the case of clinically relevant deviations from expected baseline values. In many cases, results of biological monitoring will show that exposure to hazardous substances because of a chemical incident has been below levels expected to induce adverse health effects. Such findings may be important to report to the victims of such an incident and may prevent attribution of health complaints to a physical factor (Ackermann-Liebrich et al., 1992; Edelman et al., 2003; Roorda et al., 2004; Wolff et al., 2005) .
In case it is decided not to start a biological monitoring campaign, this should be clearly communicated to the population involved in the incident. It is also important that the reasons for not proceeding with biological monitoring should be communicated appropriately and convincingly on a societal level. Information retrieved from the stepwise procedure for decision making can be used in this communication.
Conclusions
On a societal level, a disaster might cause unrest and mistrust of the government. On this level, health studies may also serve as a signal of recognition of the problems of victims. Survivors of disasters need to know that their ideas about exposure to toxic substances are being taken seriously (Van den Berg et al., 2008) . Biological monitoring as part of health studies is an intervention that might help the survivors to master control over their own situation. It has been recommended that, considering the potential of biological monitoring to yield valuable data on exposure, every opportunity should be taken to obtain blood and urine specimens from exposed workers and members of the affected population (WHO, 1997 (WHO, , 2009 ).
Many aspects need to be taken into account when deciding about the usefulness and necessity of implementing biological monitoring after a chemical incident. These include the kinetics pattern of elimination of the biomarker, the toxicity mechanism(s) involved, the chemical analytical possibilities for determining levels of the biomarker in biological tissues, and knowledge about background values of a biomarker in the general population. The stepwise approach using the proposed decision tree is considered to be a useful tool in the decision-making process after an acute chemical incident.
Appendix A
In this appendix we will describe how the elapsed time t s between the end of exposure during an incident and the last possible moment for sample collection can be calculated. We will make a distinction between two situations: first-order kinetics as typical for the elimination from body tissues of most parent compounds and their metabolites. For those biomarker that are captured in blood cells, such as hemoglobin adducts, we will also describe how to perform these calculations for biomarkers that follow zero-order kinetics. For both types of biomarkers, an example will be given.
C t s , which is defined as the concentration at the time of collection of biological tissues, should be equal to or above the limit of quantification:
LOQ indicates the minimum concentration of the biomarker at the time of sampling. It may be replaced by an alternative criterion for positive identification or by the 95 percentile background of the biomarker level in the general population if this value is substantially higher than the LOQ.
First-order elimination
When the biomarker is assumed to follow a log-linear decline in time, the value of this parameter at any time point (C ts ) after cessation of the exposure can be described as:
In which C e is the concentration of the biomarker at the end of the exposure and t 1/2; is the half-life of this parameter (in hours), and t s is the time lapsed between the end of the exposure at the chemical incident location and the time when biological materials can be collected. Equations (1) and (2) can be rewritten as:
The second part of this equation (2 ðts=t 1=2 Þ ) indicates the factor by which the concentration at the end of exposure has decreased as a function of the number of half-lives that elapsed between the end of the exposure and the moment of sampling t s .
Case 1: Benzene
The example of benzene is elaborated, based on the publication by Boogaard and Van Sittert (1995) . They concluded that the excretion of S-phenyl mercapturic acid (SPMA) is the most sensitive biomarker of exposure in urine and reported a t 1/2; of 9.0±4.5 h or urinary elimination of SPMA. Further, the following regression equation was reported for an 8-h TWA occupational exposure (DFG, 2008) : Using this equation an exposure to the 8-h AEGL-2 of 200 p.p.m. corresponds to an SPMA concentration of E9,000 mg/g creatinine. For the purpose of conversion, 1 mg/g creatinine is assumed to be equal to 1 mg/l. With a 95 percentile value (P 95 ) for the background of SPMA in urine of 7.3 mg/l (Scheepers, 2009) Ghittori et al. (1995) an air concentration of 200 p.p.m. benzene would lead to a calculated SPMA concentration of 2,006 mg/g creatinine, which would give an estimation of t s E73 h (3 days).
Zero-order elimination
For those biomarkers that follow zero-order kinetics, such as protein adducts encapsulated in circulating blood cells, another equation should be used:
C ts ¼ Àa C e t þ C e ðA:6Þ
In this equation, a is the slope of the function describing the loss of adduct per day and is dependent on the lifespan of hemoglobin, which is equal to the lifespan of the erythrocyte (t er ; Tö rnqvist et al., 2002 In chemical incidents this simplification can often be used because of the extremely high exposure relative to the value of the LOQ or the background biomarker level.
Case 2: acrylonitrile
For acrylonitrile the parameter estimates are taken from an incident described by Bader and Wrbitzky (2006) . They reported an effective half-life for the adduct of B75 days in humans. The researchers suggest that this half-life is longer than the half-life of hemoglobin (63 days) because of a depot of circulating reactive intermediates that leads to an extended internal exposure relative to the duration of external exposure. For the case study of the spill of acrylonitrile in Amersfoort, it is assumed that exposure occurs at or around the 1-h AEGL-2 of 58 p.p.m. An established linear relationship between the ambient air concentration and the level of globine adducts (DFG, 2008 ) is used to estimate the cyanoethylvaline adduct level by extrapolation from this relationship with linear equation: The value for t s is estimated to be 150 days.
Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http://www.nature.com/jes)
